ATE324450T1 - Polypeptid, das neutralisierende antikörper gegen hiv induziert - Google Patents
Polypeptid, das neutralisierende antikörper gegen hiv induziertInfo
- Publication number
- ATE324450T1 ATE324450T1 AT02710945T AT02710945T ATE324450T1 AT E324450 T1 ATE324450 T1 AT E324450T1 AT 02710945 T AT02710945 T AT 02710945T AT 02710945 T AT02710945 T AT 02710945T AT E324450 T1 ATE324450 T1 AT E324450T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- antibodies against
- neutralizing antibodies
- against hiv
- induces neutralizing
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000003472 neutralizing effect Effects 0.000 title 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0100141A FR2819256B1 (fr) | 2001-01-05 | 2001-01-05 | Polypeptide induisant des anticorps neutralisant le vih |
| FR0100848 | 2001-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE324450T1 true ATE324450T1 (de) | 2006-05-15 |
Family
ID=26212817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02710945T ATE324450T1 (de) | 2001-01-05 | 2002-01-04 | Polypeptid, das neutralisierende antikörper gegen hiv induziert |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1368478B1 (de) |
| AT (1) | ATE324450T1 (de) |
| AU (1) | AU2002229850A1 (de) |
| CA (1) | CA2431881C (de) |
| CY (1) | CY1105629T1 (de) |
| DE (1) | DE60210936T2 (de) |
| DK (1) | DK1368478T3 (de) |
| ES (1) | ES2260416T3 (de) |
| PT (1) | PT1368478E (de) |
| WO (1) | WO2002053587A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1445614A1 (de) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Verfahren zur in vitro Überwachung der Entwicklung von HIV Virus eines Individuums |
| ATE508139T1 (de) | 2003-04-11 | 2011-05-15 | Pasteur Institut | Synthetische peptid-hiv-vakzine: das cbd-epitop als effizientes immunogen zur induktion hiv- neutralisierender antikörper |
| CN1954217B (zh) * | 2004-02-06 | 2013-05-08 | 国立健康与医学研究所 | 衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途 |
| WO2014020205A2 (es) * | 2012-07-31 | 2014-02-06 | Universidad De Granada | Inmunógenos anti-vih mejorados |
| CN108997482A (zh) * | 2018-08-09 | 2018-12-14 | 东莞市朋志生物科技有限公司 | 用于检测hiv-1的合成肽 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5771599A (en) * | 1998-08-03 | 2000-02-28 | University Of Montana, The | Prevention and treatment of viral disease |
| AU2604200A (en) * | 1999-01-08 | 2000-07-24 | Panacos Pharmaceuticals, Inc. | Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41 |
-
2002
- 2002-01-04 CA CA2431881A patent/CA2431881C/en not_active Expired - Fee Related
- 2002-01-04 DK DK02710945T patent/DK1368478T3/da active
- 2002-01-04 WO PCT/FR2002/000031 patent/WO2002053587A2/fr active IP Right Grant
- 2002-01-04 EP EP02710945A patent/EP1368478B1/de not_active Expired - Lifetime
- 2002-01-04 AT AT02710945T patent/ATE324450T1/de active
- 2002-01-04 AU AU2002229850A patent/AU2002229850A1/en not_active Abandoned
- 2002-01-04 PT PT02710945T patent/PT1368478E/pt unknown
- 2002-01-04 DE DE60210936T patent/DE60210936T2/de not_active Expired - Lifetime
- 2002-01-04 ES ES02710945T patent/ES2260416T3/es not_active Expired - Lifetime
-
2006
- 2006-06-28 CY CY20061100881T patent/CY1105629T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60210936D1 (de) | 2006-06-01 |
| PT1368478E (pt) | 2006-07-31 |
| DE60210936T2 (de) | 2006-10-19 |
| CY1105629T1 (el) | 2010-12-22 |
| DK1368478T3 (da) | 2006-08-28 |
| CA2431881A1 (en) | 2002-07-11 |
| ES2260416T3 (es) | 2006-11-01 |
| WO2002053587A3 (fr) | 2003-09-25 |
| EP1368478A2 (de) | 2003-12-10 |
| EP1368478B1 (de) | 2006-04-26 |
| AU2002229850A1 (en) | 2002-07-16 |
| WO2002053587A2 (fr) | 2002-07-11 |
| CA2431881C (en) | 2011-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
| PL366579A1 (en) | Treatment of nail infections with no | |
| MXPA02007478A (es) | Vacuna contra el virus de inmunodeficiencia humana. | |
| DE60125797D1 (de) | Impfstoffzusammesetzung | |
| DK1328547T3 (da) | Identifikation og modifikation af immundominante epitoper i polypeptider | |
| ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
| WO2005089231A3 (en) | Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide | |
| DE60239682D1 (de) | Vakzine, welche gp120 zusammen mit nef und/oder tat enthält, zur immunisierung gegen hiv | |
| DK1404367T3 (da) | Anvendelse af polyklonalt anti-HIV gedeserum som et terapeutisk middel | |
| EA200400197A1 (ru) | Способы получения поливалентных бактериофагов для лечения бактериальных инфекций | |
| CY1105629T1 (el) | Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv | |
| BR0109164A (pt) | Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos | |
| DE69720065D1 (de) | Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen | |
| CY1106200T1 (el) | Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους | |
| NO20032597L (no) | Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma | |
| TW200621800A (en) | Human immunodeficiency virus vaccine | |
| HRP20030701A2 (en) | Natural antibodies active against hiv virus | |
| AU2003255866A8 (en) | Gp41 epitope and uses thereof for the treatment of hiv infections | |
| PT1152768E (pt) | Tratamento de infeccoes virais cronicas com m. vaccae | |
| ES2195861T3 (es) | Uso de (ir,4s)-4-(6-amino-9h-purin-9-il)-2-ciclopenten-1-metanol en vhb. | |
| RU2001107405A (ru) | Способ повышения статокинетической устойчивости человека | |
| FR2819256B1 (fr) | Polypeptide induisant des anticorps neutralisant le vih | |
| FR2839721B1 (fr) | Antigene polypeptidique induisant des anticorps neutralisant le vih |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1368478 Country of ref document: EP |